Table of Contents

company-logo

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.

Applied Therapeutics Dividend Announcement

• Applied Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Applied Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Applied Therapeutics Dividend History

Applied Therapeutics Dividend Yield

Applied Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Applied Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Applied Therapeutics Financial Ratios

P/E ratio-0.74
PEG ratio0.01
P/B ratio23.49
ROE-583.37%
Payout ratio0.00%
Current ratio1.06
Quick ratio1.06
Cash Ratio1.00

Applied Therapeutics Dividend FAQ

Does Applied Therapeutics stock pay dividends?
Applied Therapeutics does not currently pay dividends to its shareholders.
Has Applied Therapeutics ever paid a dividend?
No, Applied Therapeutics has no a history of paying dividends to its shareholders. Applied Therapeutics is not known for its dividend payments.
Why doesn't Applied Therapeutics pay dividends?
There are several potential reasons why Applied Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Applied Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Applied Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Applied Therapeutics a dividend aristocrat?
Applied Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Applied Therapeutics a dividend king?
Applied Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Applied Therapeutics a dividend stock?
No, Applied Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Applied Therapeutics stocks?
To buy Applied Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Applied Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.